Baronsmead Second Venture Trust (LON:BMD) Reaches New 1-Year High – Should You Buy?

Baronsmead Second Venture Trust (LON:BMDGet Free Report) hit a new 52-week high during mid-day trading on Wednesday . The stock traded as high as GBX 54 and last traded at GBX 54, with a volume of 3045475 shares. The stock had previously closed at GBX 53.

Baronsmead Second Venture Trust Stock Up 1.9%

The firm’s 50 day simple moving average is GBX 50.84 and its two-hundred day simple moving average is GBX 50.84. The stock has a market capitalization of £229.40 million, a P/E ratio of 84.38 and a beta of 0.24.

Baronsmead Second Venture Trust (LON:BMDGet Free Report) last released its quarterly earnings data on Tuesday, December 23rd. The company reported GBX 0.55 earnings per share (EPS) for the quarter. Baronsmead Second Venture Trust had a net margin of 38.32% and a return on equity of 1.95%.

Insider Buying and Selling

In other news, insider Sarah Fromson bought 8,994 shares of the stock in a transaction dated Thursday, November 20th. The shares were bought at an average cost of GBX 56 per share, with a total value of £5,036.64. Company insiders own 0.39% of the company’s stock.

Baronsmead Second Venture Trust Company Profile

(Get Free Report)

Baronsmead Second Venture Trust plc is a venture capital trust managed by ISIS Equity Partners LLP. It invests in a portfolio of unquoted companies in the United Kingdom. The trust primarily invests in the media, business services, consumer, information technology support services, technology-enabled companies, and healthcare sectors. It also invests in companies raising new share capital on the alternative investment market, as well as in technology-enabled companies in the United Kingdom.

Further Reading

Receive News & Ratings for Baronsmead Second Venture Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baronsmead Second Venture Trust and related companies with MarketBeat.com's FREE daily email newsletter.